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BACKGROUND	  
Increasing	   age,	   several	   co-­‐morbidiJes,	   environmental	   contaminaJon,	  
anJbioJc	  exposure	  and	  other	  intesJnal	  perturbaJons	  appear	  to	  be	  the	  
greatest	   risk	   factors	   for	   C.	   diﬃcile	   infecJon.	   Therefore,	   hospitalized	  
paJents	  are	  considered	  parJcularly	  vulnerable	  to	  CDI.	  
OBJECTIVES	  
The	   main	   objecJve	   of	   this	   study	   was	   to	   evaluate	   the	  
prevalence	   of	   C.	   diﬃcile	   in	   a	   Spanish	   hospital	   and	   to	  
characterise	   the	   isolates	  with	   respect	   to	   PCR-­‐ribotype,	  
anJbioJc	  resistance	  and	  toxin	  acJvity	  
	  
MATERIALS	  AND	  METHODS	  
Sampling	   The	   study	  was	   conducted	   in	   a	   1,324-­‐bed	  public	   teaching	  hospital	   in	  Oviedo,	   Spain.	  During	   a	   4-­‐month	  period	  
(from	  July	  to	  October	  2014),	  all	  paJents	  (hospitalised	  paJents	  or	  outpaJents	  in	  consultaJon)	  suspected	  to	  have	  
CDI	  were	  eligible	  to	  parJcipate.	  C.	  diﬃcile	  tesJng	  was	  performed	  on	  semisolid,	  mushy	  stools	  and	  watery/enJre	  
liquid	  feces	  (Bristol	  stool	  chart	  from	  levels	  4	  to	  7).	  
Analysis	   First	   screening	   for	   C.	   diﬃcile	   was	   performed	   using	   a	   rapid	   membrane	   enzyme	   immunoassay	   for	   the	  
simultaneous	  detecJon	  of	  C.	  diﬃcile	  glutamate	  dehydrogenase	  anJgen	  and	   toxins	  A	  and	  B	   (Cdiﬀ	  QuickChek	  
Complete®	   TechLab).	   At	   the	   same	   Jme	   fresh	   stool	   samples	   ere	   cultured	   on	   home-­‐made	   selecJve	   medium	  
CCFAT	  directly	  and	  a^er	  an	  enrichment	  step	  of	  3	  days	  in	  the	  same	  liquid	  medium.	  	  
Molecular	  
characteriza-on	  
IdenJﬁcaJon	  and	  characterisaJon	  of	  the	  colonies	  were	  done	  by	  detecJon	  of	  tpi,	  tcdA,	  tcdB	  and	  cdtA	  genes.	  
GenomEra	  CDX	  System	  C.	  diﬃcile	  (Abacus)	  was	  performed	  for	  the	  rapid	  idenJﬁcaJon	  of	  toxin	  B.	  	  Further	  
characterisaJon	  was	  performed	  by	  PCR-­‐ribotyping	  and	  Genotype	  Cdiﬀ	  test	  (Hain	  Lifescience)	  which	  detects	  
deleJons	  in	  the	  regulator	  gene	  tcdC	  and	  gyrA	  mutaJons	  associated	  with	  moxiﬂoxacin	  resistance.	  
An-microbial	  
suscep-bility	  
SuscepJbility	  to	  metronidazole,	  moxiﬂoxacin	  and	  tetracycline	  was	  determined	  by	  Etest	  strips	  (Lucron	  EliTech	  
Group)	  on	  Brucella	  Blood	  Agar	  with	  hemin	  and	  vitamin	  K1	  (Becton-­‐Dickinson)	  according	  to	  the	  manufacturing	  
instrucJons.	  Plates	  were	  anaerobically	  incubated	  at	  37°C	  for	  48H.	  The	  resistance	  (r)	  breakpoints	  for	  
metronidazole	  (Met	  r≥32	  μg/mL),	  moxiﬂoxacine	  (Mox	  r≥8	  μg/mL)	  and	  tetracycline	  (r≥8	  μg/mL)	  	  were	  those	  









Met	   Mox	   Tetra	  
001	   1	   A+B+	  CDT-­‐	   -­‐	   -­‐	   -­‐	  
002	   3	   A+B+	  CDT-­‐	   -­‐	   	  	  	  	  	  	  	  +	  (n=2)	   -­‐	  
078	   2	   A+B+	  CDT+	   -­‐	   +	   +	  
070	   1	   A+B+	  CDT-­‐	   -­‐	   -­‐	   -­‐	  
023	   1	   A+B+	  CDT-­‐	   -­‐	   -­‐	   -­‐	  
014	   3	   A+B+	  CDT-­‐	   -­‐	   -­‐	   -­‐	  
012	   1	   A+B+	  CDT-­‐	   -­‐	   -­‐	   -­‐	  
UCL	  489	   1	   A+B+	  CDT-­‐	   -­‐	   -­‐	   -­‐	  
UCL	  5a	   4	   A+B+	  CDT+	   -­‐	   +	   +	  
UCL	  16b	   1	   A+B+	  CDT-­‐	   -­‐	   +	   +	  
UCL	  9	   1	   A-­‐B-­‐	  CDT-­‐	   -­‐	   -­‐	   -­‐	  
UCL	  16o	   1	   A+B+	  CDT-­‐	   -­‐	   -­‐	   -­‐	  
UCL	  55a	   1	   A+B+	  CDT-­‐	   -­‐	   -­‐	   -­‐	  
UCL	  36a	   1	   A+B+	  CDT-­‐	   -­‐	   -­‐	   +	  
UCL	  16i	   1	   A+B+	  CDT-­‐	   -­‐	   -­‐	   -­‐	  
UCL	  108	   1	   A+B+	  CDT-­‐	   -­‐	   -­‐	   -­‐	  
UCL	  16a	   1	   A+B+	  CDT-­‐	   -­‐	   -­‐	   -­‐	  
UCL	  483	   1	   A+B+	  CDT-­‐	   -­‐	   -­‐	   -­‐	  
Table	  1.	  C.	  diﬃcile	  PCR-­‐ribotypes	  in	  hospitalized	  paJents	  and	  anJmicrobial	  
resistance	  of	  the	  isolates	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Signiﬁcance	  and	  perspec-ves	  
This	   study	   reveals	   the	   circulaJon	   of	   toxigenic	   C.	   diﬃcile	   among	  
diﬀerent	   types	  of	  paJents	   in	  a	  Spanish	  hospital.	  Most	  of	   the	   isolates	  
were	  obtained	   from	  paJents	  without	  acute/bloody	  diarrhea.	  Further	  
invesJgaJons	  will	   be	   performed	   to	   compare	   Belgian	   and	   Spanish	  C.	  




























Ø 	  22	  samples/week:	  a	  total	  of	  261	  samples	  analysed	  
Ø 	  32	  posiJve	  samples	  to	  C.	  diﬃcile	  (12.3%)	  	  
Ø 	  22	  CDI	  cases	  diagnosed	  
Ø 	  8/32	  strains	  were	  isolated	  from	  paJents	  with	  acute	  diarrhea	  	  
Figure	  1.CharacterisJcs	  of	  C.	  diﬃcile	  cases	  	  
C.	  diﬃcile	  detecJon	  
